Navigation Links
Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Comments on Study Comparing Outcomes in Prolapse Repair with Surgical Mesh or Native Tissue
Date:5/10/2013

New York, NY (PRWEB) May 10, 2013

With transvaginal mesh lawsuits mounting in courts around the country, a new study is raising additional concerns about the risks and benefits associated with the use of surgical mesh implants in pelvic organ prolapse repair, Bernstein Liebhard LLP reports. The study, which was reported at the annual meeting of the Society of Gynecologic Surgeons, found that patient satisfaction and cure rates were similar regardless of whether mesh or native tissue was used. However, subjects treated with mesh reported more complications without experiencing benefits beyond what was seen in patients who underwent native tissue repair. Among other things, enrollment in the study was halted due to a mesh erosion rate that exceeded 15%.*

“We are representing numerous women who have allegedly suffered serious vaginal mesh complications, including mesh erosion into vaginal tissue. This study further confirms that transvaginal repair of pelvic organ prolapse with surgical mesh may carry substantial risks compared to alternate procedures,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing hundreds of women in mesh implant lawsuits who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to transvaginal mesh products marketed by American Medical Systems, Inc., Boston Scientific, Inc., C.R. Bard and Ethicon, Inc.

Transvaginal Mesh Lawsuits
Transvaginal mesh has been the subject of growing safety concerns since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious transvaginal mesh side effects over a three year period. In July 2011, the FDA warned that there had been a five-fold
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note Issuance of New Order in Federal Ethicon Mesh Litigation
2. US Drug Watchdog Urges A Woman Who Has A Transvaginal Mesh Failure And Severe Medical Complications To Call Them For The Best Possible Women Lawyers
3. New York Woman Suffers Injuries Allegedly Due to Boston Scientific’s Transvaginal Mesh Device, Lawsuit Filed by Parker Waichman LLP
4. Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Protective Order in Federal C.R. Bard Vaginal Mesh Litigation, Bernstein Liebhard LLP Reports
5. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of First Bellwether Trial in New Jersey C.R. Bard Pelvic Mesh Litigation
6. Wisconsin Woman Alleges She was Injured by Transvaginal Mesh Devices in Lawsuit Filed by Parker Waichman LLP
7. US Drug Watchdog Now Urges Transvaginal Mesh Victims Who Have Erosion To Call Them Immediately For The Names Of The Very Skilled Lawyers--Who Will All Be Women
8. US Drug Watchdog Now Urges Severely Injured Victims Of A Transvaginal Mesh Failure To Call Them for the Contacts Top Women Lawyers-Nationwide
9. US Drug Watchdog Is Expanding Their Transvaginal Mesh Failure Initiative And They Are Urging Victims To Call Them For The Names Of The Best Possible Women Lawyers To Help
10. US Drug Watchdog Now Urges Transvaginal Failure Victims To Call Them For The Contacts Of National Caliber Women Lawyers If They Have Developed Severe Complications
11. US Drug Watchdog Now Urges Victims Of An Unsuccessful Transvaginal Mesh Revision Surgery Nationwide To Call Them For The Names Of The Best Lawyers-Who Will All Be Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 USARAD Holdings Inc. a ... solutions provider, including SecondOpinions.com® – consumer division is ... advanced services. The telemedicine industry pioneer is now ... , Founded and established in 1963 as the ... began as a maternity care hospital with very ...
(Date:9/2/2014)... to announce that the following papers will be ... Congress 2014, taking place in Barcelona, Spain, 30 ... strut biodegradable polymer sirolimus-eluting stent versus durable polymer ... randomised, single-blind, non-inferiority trial, Windecker et al ... surface polymer, and drug release have improved clinical ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The global ... USD 8,918.8 million by 2020, growing at an estimated ... a new study by Grand View Research, Inc. Peripheral ... plague modification devices are used for treating peripheral arterial ... of atherosclerotic plaques in arteries. These devices are used ...
(Date:9/2/2014)... Denver, Colo. (PRWEB) September 02, 2014 ... reimagined patient care, has been selected from a group ... round of the 2014 PrIME Digital Health Challenge. The ... against one another, Tuesday, Sept. 9th at the CSU ... in 2012, MyRounding is based in Denver, Colo. The ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They can ... friends, sleeping and just coping well with daily activities. ... worldwide. The medications prescribed for these conditions frequently don’t ... cases of headache and back pain are of a mechanical ... detect and fix the cause. , When a sports ...
Breaking Medicine News(10 mins):Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... you,re ready to drive again , , WEDNESDAY, Dec. 10 (HealthDay ... wheel again after orthopedic surgery or injury, but knowing when it,s ... , Orthopedic surgeons weigh in on the issue in the December ... , "Deciding when a patient can return to driving is ...
... (OTC Pink Sheets: SNDY ) is pleased to announce that ... by over 10% compared to the same time period for 2007. ... $28,509 for the same month last year. This marks the second ... of October. , , The Mammo ...
... Inc., a leading,provider of software and databases for systems ... Singapore Immunology Network (SIgN) has become a,certified GeneGo Center ... MetaCore, training and advanced support. SIgN COE will ... "We are excited ...
... Facilities , , NEW ... process, a proven commitment to clinical quality earned SigmaCare(R) ... Metropolitan Jewish Health System,s (Metropolitan) skilled nursing facilities. ... nationally recognized nonprofit organization, operates Metropolitan Jewish Geriatric Center, ...
... Pharma Services, Goodwill, , , ... NYSE: MDZ ), a leading provider of products and ... fiscal 2008 performance. , Based on preliminary information, MDS ... of $1,210 million to $1,220 million and adjusted EBITDA in the ...
... Care Insurance While They,re Still Healthy Enough to Qualify , ... If you,ve put off getting long term care insurance, ... new administration,s health plan? "I wouldn,t advise it," says Denise ... (LTCFP), one of the nation,s most experienced long term care ...
Cached Medicine News:Health News:Returning to the Road Tricky After Injury 2Health News:Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year 2Health News:A*STAR's Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Obama Health Plan Not Likely to Embrace Long Term Care, Industry Leader Says 2
(Date:9/2/2014)... -- ResMed (NYSE: RMD ) has introduced the ... the United States . The Astral platform is ... support ventilators. ResMed,s new Astral life ... for patients suffering from neuromuscular disease, chronic obstructive pulmonary ... The U.S. launch comes on the heels of Astral,s ...
(Date:9/2/2014)... 2014   Mast Therapeutics, Inc . (NYSE MKT: MSTX) today ... , will present at the Rodman and Renshaw 16 th ... p.m. Eastern time in the Holmes II Salon at The New ... Interested parties can access a live audio webcast and ... . An archived presentation will be available on the web site ...
(Date:9/2/2014)... Sept. 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... products marketed as XIAFLEX ® in the U.S. and ... President, Tom Wegman , will present at the following ... Rodman & Renshaw 16 th Annual ... Tuesday, September 9, 2014 at 9:10 a.m. EDT ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
... SEATTLE, Jan. 13, 2011 Dendreon Corporation (Nasdaq: ... market and other conditions, $500 million aggregate principal amount of ... an offering registered under the Securities Act of 1933, as ... cash, shares of Dendreon,s common stock (the "Common Stock") or ...
... BURLINGAME, Calif., Jan. 13, 2011 Collaborative Drug Discovery, Inc. ... has extended its previous grant to CDD to create a ... drugs against tuberculosis (TB). The TB bacillus infects approximately one ... 1.5 million people every year. Over the past ...
Cached Medicine Technology:Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 3Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 4Collaborative Drug Discovery Receives New Funding to Support Tuberculosis Drug Discovery Screening Efforts and Industrial-Academic Collaborations 2
Inquire...
Inquire...
... The compact Allegra X-22 Series is up to ... With a library of 11 rotors, the Allegra X-22 ... Features: Only 18 inches / 46 ... to 22,065 x g 3 different ways to ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products: